Advanced and/or metastatic solid tumors known to express B7-H3

Clinical trials for Advanced and/or metastatic solid tumors known to express B7-H3 explained in plain language.

Never miss a new study

Get alerted when new Advanced and/or metastatic solid tumors known to express B7-H3 trials appear

Sign up with your email to follow new studies for Advanced and/or metastatic solid tumors known to express B7-H3, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Can a targeted 'Missile' drug shrink Hard-to-Treat tumors?

Disease control Recruiting now

This trial tests an experimental drug called MX006 in people with advanced solid tumors that carry a specific marker, B7-H3. MX006 is designed to deliver a toxic payload directly to cancer cells while sparing healthy tissue. The study has two parts: first, to find the safest dose…

Matched conditions: ADVANCED AND/OR METASTATIC SOLID TUMORS KNOWN TO EXPRESS B7-H3

Phase 1 • Sponsor: Myricx Pharma Limited • Aim: Disease control

Last updated Sep 10, 2026 00:00 UTC

Advanced and/or metastatic solid tumors known to express B7-H3

Get alerted when new Advanced and/or metastatic solid tumors known to express B7-H3 trials appear

Can a targeted 'Missile' drug shrink Hard-to-Treat tumors?